TABLE 2.
Microphysiological systems for tumor-stromal-immune study of pancreatic ductal adenocarcinoma.
| Cancer model | Reference | Key features | Cell types | Key findings |
|---|---|---|---|---|
| PDAC | Haque et al. (2022) | Device with 2 chambers separated by porous membrane, pump | Patient-derived PDAC organoids, PSCs and macrophages | Anti-stromal compounds enhance PDAC chemotherapy response in tumor chip |
| PDAC | Mollica et al. (2021) | Microfluidic device with 2 lateral channels and central chamber | ECs, PSCs, Panc-1 PDAC cells, and T cells | EC barrier decreases T cell infiltration into PSCs + Panc-1 |
| PDAC | Lee et al. (2020) | Microfluidic chip with 4 connected channels | Panc-1 PDAC cells and macrophages | Interstitial flow and cancer cell signaling increases macrophage motility |